Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2015 | 07-2014 | 07-2013 | 07-2012 | 07-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,193 | -1 | -8,554 | -9,490 | -21,676 |
| Depreciation Amortization | 381 | 368 | 464 | 613 | 1,679 |
| Accounts receivable | N/A | N/A | N/A | N/A | 62 |
| Other Working Capital | -194 | -596 | 210 | -578 | 3,159 |
| Other Operating Activity | -878 | -3,345 | 4,220 | 1,412 | -156 |
| Operating Cash Flow | $-2,885 | $-3,574 | $-3,661 | $-8,044 | $-16,931 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 884 | 1,764 | 4,951 | -52 |
| Purchase Sale Intangibles | -91 | -90 | -79 | -174 | -235 |
| Other Investing Activity | -91 | -90 | -79 | -174 | -235 |
| Investing Cash Flow | $-91 | $794 | $1,685 | $4,777 | $-287 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 829 | 3,562 | 0 |
| Debt Repayment | N/A | -607 | -1,833 | -4,822 | -125 |
| Common Stock Issued | 6 | 2,303 | 1,850 | 31 | 3,940 |
| Other Financing Activity | 475 | 2,655 | 2,615 | 1,975 | 2,315 |
| Financing Cash Flow | $481 | $4,351 | $3,461 | $747 | $6,130 |
| Exchange Rate Effect | -25 | -11 | -22 | -32 | 7 |
| Beginning Cash Position | 3,270 | 1,709 | 246 | 2,799 | 13,881 |
| End Cash Position | 750 | 3,270 | 1,709 | 246 | 2,799 |
| Net Cash Flow | $-2,520 | $1,561 | $1,463 | $-2,553 | $-11,082 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,885 | -3,574 | -3,661 | -8,044 | -16,931 |
| Capital Expenditure | N/A | N/A | N/A | -2 | -52 |
| Free Cash Flow | -2,885 | -3,574 | -3,661 | -8,046 | -16,984 |